A pair of pioneering skin cancer researchers, Georgina Long and Richard Scolyer, have been named as joint Australians of the Year for 2024 by the National Australia Day Council (NADC). The co-directors of the Melanoma Institute Australia were awarded this honor for their groundbreaking work in the field of cancer research. Through their partnership, Long and Scolyer have developed immunotherapy as a treatment for melanoma, the most dangerous type of skin cancer, and have been credited with saving thousands of lives.
Their tireless efforts have not only revolutionized the way melanoma is treated but have also given hope to patients with other forms of cancer. In 2023, Long adapted their immunotherapy treatment to tackle brain cancer after her colleague Scolyer was diagnosed with an incurable form of the disease. Scolyer was the first person in the world with brain cancer to undergo pre-surgery combination immunotherapy, an experimental treatment that carries the risk of shortening his life but has the potential to benefit future patients.
During his emotional acceptance speech, Scolyer expressed his determination not to let a terminal diagnosis hold him back. He described the decision to take on Long’s groundbreaking plan as a no-brainer, seeing it as an opportunity to crack another incurable cancer and make a difference, not just for himself but for others facing similar challenges.
The NADC acknowledged Scolyer’s bravery and selflessness in undertaking this experimental treatment, which could have significant implications for the future of cancer research. Scolyer’s documented treatment and progress have provided invaluable insights into the effectiveness of immunotherapy and have inspired hope in countless individuals battling cancer.
Georgina Long and Richard Scolyer’s partnership has exemplified the power of collaboration and innovation in the fight against cancer. By pushing the boundaries of medical science, they have brought transformational changes to the lives of cancer patients and their families. Their pioneering work serves as a beacon of hope for the countless individuals affected by this devastating disease worldwide.
As recipients of the prestigious Australians of the Year award, Long and Scolyer have become ambassadors for cancer research and advocates for improved access to innovative treatments. Their dedication and achievements serve as an inspiration to aspiring researchers and remind us all of the importance of relentless pursuit in the face of adversity.
The recognition of Long and Scolyer as joint Australians of the Year for 2024 marks a significant milestone in the field of cancer research. Their groundbreaking contributions have not only transformed the lives of individuals affected by melanoma and brain cancer but have also opened up new possibilities for tackling other forms of cancer. Through their pioneering work, they have redefined what is possible in the fight against this insidious disease.
Their joint award is a fitting tribute to their unwavering commitment and the exceptional impact they have made in the world of cancer research. As Georgina Long and Richard Scolyer continue their groundbreaking work, their legacy will undoubtedly extend far beyond the borders of Australia, bringing hope and healing to individuals around the globe who are affected by cancer.
